CannBioRx Life Sciences (ATNFW) has had the highest return since January 1, 2025 by a micro-cap US stock, returning 4,287.8%.

ASSET	% RETURN
CannBioRx Life Sciences (ATNFW)	4,287.76%
Kindly (NAKA)	1,002.42%
SRM Entertainment, Inc Common Stock (SRM)	993.3%
Global Interactive Technologies (GITS)	821.16%
Kindly MD, Inc Common Stock (KDLY)	779.03%
Asset Entities Inc Class B Common Stock (ASST)	756%
Imunon (IMNN)	678.87%
mF International Limited Ordinary Shares (MFI)	618.89%
M3-Brigade Acquisition V Corp Warrant (MBAVW)	618.03%
Lixte Biotechnology (LIXTW)	614.29%
Dominari (DOMH)	579.62%
Abits (ABTS)	559.87%
Quantum BioPharma (QNTM)	490.79%
Junee Limited Ordinary Shares (JUNE)	465.35%
Airnet Technology (ANTE)	464.74%
ABVC BioPharma (ABVC)	459.32%
Immunoprecise Antibodies (IPA)	387.8%
Matinas BioPharma (MTNB)	370.12%
VivoPower International (VVPR)	368.89%
Epsium Enterprise Limited Ordinary Shares (EPSM)	346.43%
CervoMed (CRVO)	321.67%
Palvella Therapeutics (PVLA)	307.41%
Connexa Sports Technologies (YYAI)	251.33%
Roma Green Finance Limited Ordinary Shares (ROMA)	246.15%
Mobile-health Network Solutions Class A Ordinary Shares (MNDR)	233.23%

Micro-cap stocks are treated as having a market cap of <= $300M.